Avalo Therapeutics, Inc. (AVTX)

Avalo Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	93.43	7.42	13.17	54.59	18.92	3.61
Cash & Short-Term Investments	93.43	7.42	13.17	54.59	18.92	3.61
Cash Growth	1381.31%	-43.71%	-75.87%	188.52%	424.15%	-66.10%
Accounts Receivable	-	-	-	1.06	2.18	1
Other Receivables	0.03	0.14	1.92	3.74	2.21	0.14
Receivables	0.03	0.14	1.92	4.8	4.39	5.24
Inventory	-	-	0.02	0.04	0	0.02
Prepaid Expenses	2.44	0.84	1.29	2.37	2.66	0.71
Restricted Cash	-	0	0.02	0.05	0.04	0.02
Other Current Assets	-	-	-	-	-	8.13
Total Current Assets	95.89	8.4	16.42	61.85	26.01	17.72
Property, Plant & Equipment	1.78	1.97	2.41	2.7	1.61	1.45
Goodwill	10.5	10.5	14.41	14.41	14.41	14.41
Other Intangible Assets	-	-	-	0.04	1.59	2.43
Other Long-Term Assets	0.13	0.13	0.13	1.23	0.15	0.1
Total Assets	108.31	20.99	33.37	80.21	43.76	36.11
Accounts Payable	0.65	0.45	2.88	3.37	2.57	2.08
Accrued Expenses	3.72	1.76	10.51	14.29	8.86	3.11
Current Portion of Long-Term Debt	-	-	5.93	-	-	-
Current Portion of Leases	0.55	0.54	0.53	0.49	0.43	0.16
Current Income Taxes Payable	-	-	-	-	-	0.55
Current Unearned Revenue	-	-	0.09	-	-	-
Other Current Liabilities	91.47	1.87	2.17	1.74	3.36	6.26
Total Current Liabilities	96.4	4.62	22.11	19.89	15.23	12.16
Long-Term Debt	-	-	13.49	32.83	-	-
Long-Term Leases	1.18	1.37	1.71	2.02	1.04	1.11
Long-Term Deferred Tax Liabilities	0.17	0.16	0.14	0.11	0.09	0.09
Other Long-Term Liabilities	12.71	7.55	6.83	2.28	2.84	1.76
Total Liabilities	110.46	13.69	44.28	57.13	19.19	15.11
Common Stock	0	0	-	0.01	0.08	0.05
Additional Paid-In Capital	344.35	342.44	292.91	285.24	202.28	135.24
Retained Earnings	-357.96	-335.13	-303.82	-262.17	-177.79	-114.29
Total Common Equity	-13.61	7.3	-10.92	23.08	24.56	21
Shareholders' Equity	-2.15	7.3	-10.92	23.08	24.56	21
Total Liabilities & Equity	108.31	20.99	33.37	80.21	43.76	36.11
Total Debt	1.73	1.9	21.66	35.34	1.46	1.27
Net Cash (Debt)	91.7	5.51	-8.49	19.25	17.46	2.34
Net Cash Growth	-	-	-	10.28%	645.41%	-78.00%
Net Cash Per Share	126.59	19.85	-216.49	531.87	684.21	117.97
Filing Date Shares Outstanding	1.03	1.03	0.06	0.04	0.56	1.22
Total Common Shares Outstanding	1.03	0.8	0.04	0.04	0.55	1.22
Working Capital	-0.5	3.78	-5.7	41.96	10.78	5.56
Book Value Per Share	-13.16	9.11	-277.78	589.35	44.33	17.27
Tangible Book Value	-24.11	-3.2	-25.32	8.64	8.57	4.16
Tangible Book Value Per Share	-23.31	-3.99	-644.47	220.48	15.46	3.42
Machinery	-	0.28	0.34	0.24	0.21	0.15
Leasehold Improvements	-	0.9	0.74	0.74	0.66	0.66

Source: S&P Capital IQ. Standard template. Financial Sources.